NDC 0049-3190

VFEND

Voriconazole

VFEND is a Intravenous Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by Roerig. The primary component is Voriconazole.

Product ID0049-3190_037c3fa0-f5fc-454f-aaab-f5b0e34e616b
NDC0049-3190
Product TypeHuman Prescription Drug
Proprietary NameVFEND
Generic NameVoriconazole
Dosage FormInjection, Powder, Lyophilized, For Solution
Route of AdministrationINTRAVENOUS
Marketing Start Date2012-10-24
Marketing CategoryNDA / NDA
Application NumberNDA021267
Labeler NameRoerig
Substance NameVORICONAZOLE
Active Ingredient Strength10 mg/mL
Pharm ClassesAzole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA]
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 0049-3190-38

20 mL in 1 VIAL, SINGLE-USE (0049-3190-38)
Marketing Start Date2012-10-24
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 0049-3190-01 [00049319001]

VFEND INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Marketing CategoryNDA
Application NumberNDA021267
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2002-05-24

NDC 0049-3190-28 [00049319028]

VFEND INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Marketing CategoryNDA
Application NumberNDA021267
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2003-03-28

NDC 0049-3190-38 [00049319038]

VFEND INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Marketing CategoryNDA
Application NumberNDA021267
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2012-10-24

Drug Details

Active Ingredients

IngredientStrength
VORICONAZOLE10 mg/mL

OpenFDA Data

SPL SET ID:ce3ef5cf-3087-4d92-9d94-9eb8287228db
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 352220
  • 546624
  • 465355
  • 349435
  • 349434
  • 351209
  • 352219
  • 352218
  • UPC Code
  • 0300493170304
  • Pharmacological Class

    • Azole Antifungal [EPC]
    • Azoles [CS]
    • Cytochrome P450 3A4 Inhibitors [MoA]
    • Cytochrome P450 2C19 Inhibitors [MoA]
    • Cytochrome P450 2C9 Inhibitors [MoA]

    NDC Crossover Matching brand name "VFEND" or generic name "Voriconazole"

    NDCBrand NameGeneric Name
    0049-3160VFENDvoriconazole
    0049-3170VFENDvoriconazole
    0049-3180VFENDvoriconazole
    0049-3190VFENDvoriconazole
    55154-2725VFENDVFEND
    0049-4190VFENDVFEND

    Trademark Results [VFEND]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    VFEND
    VFEND
    78469910 3017665 Live/Registered
    PFIZER IRELAND PHARMACEUTICALS
    2004-08-19
    VFEND
    VFEND
    76269065 not registered Dead/Abandoned
    Pfizer Inc.
    2001-06-07
    VFEND
    VFEND
    75122046 2455588 Live/Registered
    PFIZER IRELAND PHARMACEUTICALS
    1996-06-19

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.